Literature DB >> 18032488

Human papillomavirus E1 helicase interacts with the WD repeat protein p80 to promote maintenance of the viral genome in keratinocytes.

Alexandra Côté-Martin1, Cary Moody, Amélie Fradet-Turcotte, Claudia M D'Abramo, Michaël Lehoux, Simon Joubert, Guy G Poirier, Benoit Coulombe, Laimonis A Laimins, Jacques Archambault.   

Abstract

Due to the limited coding capacity of their small genomes, human papillomaviruses (HPV) rely extensively on host factors for the completion of their life cycles. Accordingly, most HPV proteins, including the replicative helicase E1, engage in multiple protein interactions. The fact that conserved regions of E1 have not yet been ascribed a function prompted us to use tandem affinity protein purification (TAP) coupled to mass spectrometry to identify novel targets of this helicase. This method led to the discovery of a novel interaction between the N-terminal 40 amino acids of HPV type 11 (HPV11) E1 and the cellular WD repeat protein p80 (WDR48). We found that interaction with p80 is conserved among E1 proteins from anogenital HPV but not among cutaneous or animal types. Colocalization studies showed that E1 can redistribute p80 from the cytoplasm to the nucleus in a manner that is dependent on the E1 nuclear localization signal. Three amino acid substitutions in E1 proteins from HPV11 and -31 were identified that abrogate binding to p80 and its relocalization to the nucleus. In HPV31 E1, these substitutions reduced but did not completely abolish transient viral DNA replication. HPV31 genomes encoding two of the mutant E1 proteins were not maintained as episomes in immortalized primary keratinocytes, whereas one encoding the third mutant protein was maintained at a very low copy number. These findings suggest that the interaction of E1 with p80 is required for efficient maintenance of the viral episome in undifferentiated keratinocytes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18032488      PMCID: PMC2224424          DOI: 10.1128/JVI.01405-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Differentiation-induced changes in promoter usage for transcripts encoding the human papillomavirus type 31 replication protein E1.

Authors:  D J Klumpp; L A Laimins
Journal:  Virology       Date:  1999-04-25       Impact factor: 3.616

2.  Interaction between cyclin-dependent kinases and human papillomavirus replication-initiation protein E1 is required for efficient viral replication.

Authors:  T Ma; N Zou; B Y Lin; L T Chow; J W Harper
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

3.  Temporal usage of multiple promoters during the life cycle of human papillomavirus type 31b.

Authors:  M A Ozbun; C Meyers
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

4.  Interactions of the papovavirus DNA replication initiator proteins, bovine papillomavirus type 1 E1 and simian virus 40 large T antigen, with human replication protein A.

Authors:  Y Han; Y M Loo; K T Militello; T Melendy
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

5.  DNA replication of human papillomavirus type 31 is modulated by elements of the upstream regulatory region that lie 5' of the minimal origin.

Authors:  W G Hubert; T Kanaya; L A Laimins
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

6.  Active domains of human papillomavirus type 11 E1 protein for origin replication.

Authors:  Y Sun; H Han; D J McCance
Journal:  J Gen Virol       Date:  1998-07       Impact factor: 3.891

7.  Human Hsp70 and Hsp40 chaperone proteins facilitate human papillomavirus-11 E1 protein binding to the origin and stimulate cell-free DNA replication.

Authors:  J S Liu; S R Kuo; A M Makhov; D M Cyr; J D Griffith; T R Broker; L T Chow
Journal:  J Biol Chem       Date:  1998-11-13       Impact factor: 5.157

8.  Functional interaction between the bovine papillomavirus virus type 1 replicative helicase E1 and cyclin E-Cdk2.

Authors:  N Cueille; R Nougarede; F Mechali; M Philippe; C Bonne-Andrea
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

9.  A C-terminal helicase domain of the human papillomavirus E1 protein binds E2 and the DNA polymerase alpha-primase p68 subunit.

Authors:  P J Masterson; M A Stanley; A P Lewis; M A Romanos
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

10.  Human papillomavirus DNA replication. Interactions between the viral E1 protein and two subunits of human dna polymerase alpha/primase.

Authors:  K L Conger; J S Liu; S R Kuo; L T Chow; T S Wang
Journal:  J Biol Chem       Date:  1999-01-29       Impact factor: 5.157

View more
  26 in total

1.  Mapping the disease protein interactome: toward a molecular medicine GPS to accelerate drug and biomarker discovery.

Authors:  Benoit Coulombe
Journal:  J Proteome Res       Date:  2010-11-15       Impact factor: 4.466

2.  Inhibition of human papillomavirus DNA replication by an E1-derived p80/UAF1-binding peptide.

Authors:  Michaël Lehoux; Amélie Fradet-Turcotte; Mathieu Lussier-Price; James G Omichinski; Jacques Archambault
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

3.  Artificial Recruitment of UAF1-USP Complexes by a PHLPP1-E1 Chimeric Helicase Enhances Human Papillomavirus DNA Replication.

Authors:  David Gagnon; Michaël Lehoux; Jacques Archambault
Journal:  J Virol       Date:  2015-04-01       Impact factor: 5.103

Review 4.  The E1 proteins.

Authors:  Monika Bergvall; Thomas Melendy; Jacques Archambault
Journal:  Virology       Date:  2013-09-10       Impact factor: 3.616

5.  E1-mediated recruitment of a UAF1-USP deubiquitinase complex facilitates human papillomavirus DNA replication.

Authors:  Michaël Lehoux; David Gagnon; Jacques Archambault
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

6.  Development of quantitative and high-throughput assays of polyomavirus and papillomavirus DNA replication.

Authors:  Amélie Fradet-Turcotte; Geneviève Morin; Michaël Lehoux; Peter A Bullock; Jacques Archambault
Journal:  Virology       Date:  2010-01-15       Impact factor: 3.616

7.  Nuclear accumulation of the papillomavirus E1 helicase blocks S-phase progression and triggers an ATM-dependent DNA damage response.

Authors:  Amélie Fradet-Turcotte; Fanny Bergeron-Labrecque; Cary A Moody; Michaël Lehoux; Laimonis A Laimins; Jacques Archambault
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

8.  HPV episome levels are potently decreased by pyrrole-imidazole polyamides.

Authors:  Terri G Edwards; Kevin J Koeller; Urszula Slomczynska; Kam Fok; Michael Helmus; James K Bashkin; Chris Fisher
Journal:  Antiviral Res       Date:  2011-06-02       Impact factor: 5.970

9.  Characterization of papillomavirus E1 helicase mutants defective for interaction with the SUMO-conjugating enzyme Ubc9.

Authors:  Amélie Fradet-Turcotte; Karine Brault; Steve Titolo; Peter M Howley; Jacques Archambault
Journal:  Virology       Date:  2009-12-20       Impact factor: 3.616

Review 10.  Targeting human papillomavirus genome replication for antiviral drug discovery.

Authors:  Jacques Archambault; Thomas Melendy
Journal:  Antivir Ther       Date:  2013-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.